HUP0303496A3 - Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof - Google Patents

Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof

Info

Publication number
HUP0303496A3
HUP0303496A3 HU0303496A HUP0303496A HUP0303496A3 HU P0303496 A3 HUP0303496 A3 HU P0303496A3 HU 0303496 A HU0303496 A HU 0303496A HU P0303496 A HUP0303496 A HU P0303496A HU P0303496 A3 HUP0303496 A3 HU P0303496A3
Authority
HU
Hungary
Prior art keywords
venlafaxine
preparing
processes
crystalline
base
Prior art date
Application number
HU0303496A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27500045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0303496(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of HUP0303496A2 publication Critical patent/HUP0303496A2/hu
Publication of HUP0303496A3 publication Critical patent/HUP0303496A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10Separation; Purification; Stabilisation; Use of additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0303496A 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof HUP0303496A3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24157700P 2000-10-19 2000-10-19
US25886100P 2000-12-29 2000-12-29
US27872101P 2001-03-26 2001-03-26
US29246901P 2001-05-21 2001-05-21
PCT/US2001/051017 WO2002045658A2 (en) 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof

Publications (2)

Publication Number Publication Date
HUP0303496A2 HUP0303496A2 (hu) 2004-01-28
HUP0303496A3 true HUP0303496A3 (en) 2005-08-29

Family

ID=27500045

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303496A HUP0303496A3 (en) 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof

Country Status (20)

Country Link
US (1) US20020143211A1 (hu)
EP (1) EP1334082A4 (hu)
JP (2) JP2004530638A (hu)
KR (1) KR20030059206A (hu)
CN (1) CN1620420A (hu)
AU (1) AU2002241764A1 (hu)
CA (1) CA2426158A1 (hu)
CZ (1) CZ20031298A3 (hu)
DE (1) DE01988460T1 (hu)
ES (1) ES2206082T1 (hu)
HR (1) HRP20030392A2 (hu)
HU (1) HUP0303496A3 (hu)
IL (2) IL155400A0 (hu)
IS (1) IS6789A (hu)
MX (1) MXPA03003459A (hu)
NO (1) NO20031743L (hu)
PL (1) PL365895A1 (hu)
SK (1) SK5762003A3 (hu)
WO (1) WO2002045658A2 (hu)
YU (1) YU30203A (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU1234002A (en) * 2000-10-31 2002-05-15 Ciba Sc Holding Ag Crystalline forms of venlafaxine hydrochloride
HUP0104872A3 (en) * 2001-11-13 2004-04-28 Egis Gyogyszergyar Nyilvanosan New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
US7030164B2 (en) * 2001-12-05 2006-04-18 Wyeth Crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
AU2002247945A1 (en) * 2001-12-13 2003-06-23 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
AR039166A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Composiciones de venlafaxina base
WO2003082804A1 (en) 2002-03-28 2003-10-09 Synthon B.V. Venlafaxine besylate
AU2003226751A1 (en) 2002-03-28 2003-10-13 Synthon B.V. Low water-soluble venlafaxine salts
DE10359154A1 (de) 2003-12-16 2005-07-28 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7544841B2 (en) * 2004-10-20 2009-06-09 Mitsubishi Tanabe Pharma Corporation Production method of phenylethanolamine compound, and its intermediate
US20070129562A1 (en) * 2005-10-19 2007-06-07 Kansal Vinod K Process for the preparation of highly pure 1-[2- dimethylamino-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride
WO2007049302A2 (en) * 2005-10-28 2007-05-03 Ind-Swift Laboratories Limited An improved process for the preparation of pure venlafaxine
RU2461542C2 (ru) 2006-06-27 2012-09-20 Сандоз Аг Новый способ получения соли
CA2657912A1 (en) * 2006-07-14 2008-04-03 Carmen Arnalot Aguilar Improved processes for preparing venlafaxine base and salts thereof
RU2576665C2 (ru) * 2010-10-01 2016-03-10 Йоуксин ЛИ Полиморфы 4-[2-диметиламино-1-(1-гидроксициклогексил)этил]фенил 4-метилбензоата гидрохлорида, способы их получения и использование
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
AR255595A1 (hu) 1994-07-13 2002-05-24 Gador Sa
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU1234002A (en) * 2000-10-31 2002-05-15 Ciba Sc Holding Ag Crystalline forms of venlafaxine hydrochloride
WO2002046140A1 (en) * 2000-12-07 2002-06-13 Dr. Reddy's Laboratories Ltd. Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
NO20031743L (no) 2003-06-18
JP2004530638A (ja) 2004-10-07
JP2008239629A (ja) 2008-10-09
WO2002045658A3 (en) 2003-01-16
US20020143211A1 (en) 2002-10-03
CA2426158A1 (en) 2002-06-13
IL196287A0 (en) 2011-08-01
AU2002241764A1 (en) 2002-06-18
HRP20030392A2 (en) 2005-04-30
HUP0303496A2 (hu) 2004-01-28
WO2002045658A2 (en) 2002-06-13
IL155400A0 (en) 2003-11-23
PL365895A1 (en) 2005-01-10
CN1620420A (zh) 2005-05-25
MXPA03003459A (es) 2005-04-29
ES2206082T1 (es) 2004-05-16
YU30203A (sh) 2006-08-17
EP1334082A2 (en) 2003-08-13
KR20030059206A (ko) 2003-07-07
EP1334082A4 (en) 2006-02-01
DE01988460T1 (de) 2004-04-22
CZ20031298A3 (cs) 2003-10-15
SK5762003A3 (en) 2003-11-04
NO20031743D0 (no) 2003-04-15
IS6789A (is) 2003-04-15

Similar Documents

Publication Publication Date Title
IL196287A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof
HUP0204010A3 (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and their use
EP1463711A4 (en) "NEW POLYMORPH OF SERTRALINE HYDROCHLORIDE AND COMPOSITION CONTAINING THEREOF, NEW METHODS OF PREPARING SERTRALINE HYDROCHLORIDE POLYMORPHES AND AMORPH FORM"
IL149050A0 (en) Polymorphic forms of sertraline hydrochloride
AP2004002989A0 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
HUP0700037A2 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
HUP0501066A2 (en) Process for preparing 4-aminodiphenylamine
HUP0400299A2 (en) Polymorphs of fexofenadine hydrochloride
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
EP1406855A4 (en) NOVEL PROCESS FOR THE PREPARATION OF RAC-BICALUTAMIDE AND INTERMEDIATE PRODUCTS THEREOF
AU2001235970A1 (en) Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
AU2002247945A1 (en) Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
SI2181982T1 (sl) Postopek za pripravo venlafaksin hidroklorida oblike I
EP1295864A4 (en) PROCESS FOR THE PREPARATION OF 1,5-DIAMINONAPHTHALINES
EP1242362A4 (en) METHOD FOR PRODUCING FLUOXETINE HYDROCHLORIDE
PL372137A1 (en) A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form
HUP0302144A3 (en) Process of preparation of aliphatic amines
PL376832A1 (pl) Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny
AU2002308095A1 (en) Process for preparing sertraline hydrochloride polymorphic form ii
AU2003244886A1 (en) Process for preparing tramadol hydrochloride and/or tramadol momohydrate
AU2002347399A1 (en) Venlafaxine hydrochloride polymorphs
CZ20011502A3 (cs) Způsob výroby antidiabetika

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees